U.S. federal trademark · Serial No. 97338791 · Reg. No. 922743436
Research and development of technology in the field of cancer killer virus technology or Oncolytics (Ovs), designed to target tumors in the central nervous system (CNS); Research and development in the field of technologies, techniques and methods in the treatment of diseases and in the field of health and medicine; Scientific study and research in the field(s) of biochemistry and biotechnology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.